Navigation Links
NicOx Announces Departure of Damian Marron for CEO Position
Date:5/27/2008

e-donating technology to develop an internal portfolio of New Chemical Entities (NCEs) in the therapeutic areas of inflammatory and cardio-metabolic disease.

Resources are focused on the development of naproxcinod, a proprietary NCE and the first compound in the Cyclooxygenase-Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents, which is in phase 3 clinical studies for the treatment of the signs and symptoms of osteoarthritis, with final phase 3 results anticipated in 2008.

Beyond naproxcinod, NicOx has a pipeline containing multiple nitric oxide-donating NCEs, which are in development internally and with partners, including Pfizer Inc and Merck & Co., Inc., for the treatment of prevalent and underserved diseases, such as atherosclerosis, hypertension, glaucoma and Chronic Obstructive Pulmonary Disease (COPD).

NicOx S.A. is headquartered in France and is listed on the Euronext Paris Stock Exchange (Compartment B: Mid Caps).

This press release contains certain forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in the forward-looking statements.

For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of NicOx S.A. to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Document de Reference filed with the AMF, which is available on the AMF website (http://www.amf-france.org) or on NicOx S.A.'s website (http://www.nicox.com).


'/>"/>
SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NicOx Signs Agreement for the Commercial Manufacture of Naproxcinod Drug Substance
2. NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis
3. NicOx to Present at Financial Conferences in New York on November 27, 28 and 29
4. NicOx Opens U.S. Headquarters in New Jersey
5. CellCyte Genetics Corporation Announces Launch of Comprehensive Web site Powered by PRNewswire Investor Room Backend Technology
6. Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkins Lymphoma
7. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
10. Amnis Announces Release of Its Extended Depth of Field Option for The ImageStream(R) System
11. Amarin Announces Completion of the First Tranche of $60 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 18, 2014 Reports from ... the United States suffer from one or more chronic ... or cancer. Medication can address some of these diseases, ... activities that many sufferers face. While implanted nerve stimulation ... stimulate the whole nerve, which can induce side effects. ...
(Date:12/19/2014)... CA (PRWEB) December 18, 2014 With ... limited time special on Sartorius Biohit products . ... on mLINE pipettes, Picus Electronic Pipette Trade-in Program, and ... Health and Safety officers around the world. They are ... pipetting. Other features include:, ,     Full volume ...
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, Inc. ... the treatment of chronic pain, announced the results of ... "This was a transformational year in Relmada,s history ... for our company," said Sergio Traversa , chief ... have executed on key financial, human resource and clinical ...
(Date:12/17/2014)... Achim Noack has been named global vice ... this position, Noack will assist Jerry Stoller, CEO and ... strategy and supervise global marketing management and implementation of ... knowledge and experience in the crop protection industry,” says ... innovative thinking will be a great asset for Stoller ...
Breaking Biology Technology:Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2
... and Other Packaging Uses, MELBOURNE, Australia, and ... ) and Plantic Technologies Limited, an Australian company,specializing ... the development and sale of renewably sourced polymers ... development of new, renewably sourced,resins and sheet materials ...
... Md., Sept. 26 Micromet, Inc.,(Nasdaq: MITI ... of,novel, proprietary antibody-based products for cancer, inflammation and,autoimmune ... and,Chief Executive Officer of Micromet, will present at ... Forum in Zurich, Switzerland on,Tuesday, October 2, 2007 ...
... To Accelerate Trials and Commercialization, PALO ALTO, ... Board: AVGO), a late-stage biotechnology company that,develops central ... it had conducted an initial closing of its,private ... Company received gross proceeds of $3,110,000 and in ...
Cached Biology Technology:DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration 2DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration 3Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum 2Avicena Group Announces Closing of Private Offering 2
(Date:12/17/2014)... 2014 Research and Markets ( ... "Samsung Galaxy S5 - Home Button Synaptics ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... technology than the iPhone 5S, Samsung introduces for ... product. The Galaxy S5 home button ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... engineering at the UCLA Henry Samueli School of Engineering ... biochemistry in the UCLA Division of Physical Sciences, has ... Award from the U.S. Environmental Protection Agency. ... by leading researchers and industrial innovators who are making ...
... Insulin Suppresses Mosquito Immune System: Increasing Cases of Type II ... the mosquito immune system, according to a paper in the ... malaria might seem to go together like baseball and hotdogs, ... spread among H. sapiens . "A fair ...
... June 19, 2012 A study published in the June ... of Child and Adolescent Psychiatry found that young children ... have a higher prevalence of mental health problems and that ... from the National Survey of Child and Adolescent Well-Being II ...
Cached Biology News:UCLA's Yi Tang receives Presidential Green Chemistry Challenge Award from EPA 2UCLA's Yi Tang receives Presidential Green Chemistry Challenge Award from EPA 3Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3Tips from the Journals of the American Society for Microbiology 4Tips from the Journals of the American Society for Microbiology 5Tips from the Journals of the American Society for Microbiology 6Tips from the Journals of the American Society for Microbiology 7Child welfare investigation predicts mental health problems in young children 2
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
... CellBIND surface is produced by a ... more hydrophilic surface giving more consistent, ... and yields. CellBIND enhances cell attachment ... reduced serum or serum-free medium. • ...
... array system, 100-240 V, uses multiplex suspension ... analysis of up to 100 proteins and ... suspension array is composed of up to ... may be conjugated with a unique reactant ...
Biology Products: